Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors
QMRO Home
Barts Cancer Institute
Centre for Haemato-Oncology
ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors
QMRO Home
Barts Cancer Institute
Centre for Haemato-Oncology
ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors